Prescribing Through a Screen: The Dosing Challenges Patients and Providers Face in a Telehealth-First World

The rise of telehealth has reshaped American healthcare in ways that were difficult to imagine a decade ago. What began as an emergency accommodation during the COVID-19 pandemic has become a permanent fixture of how millions of patients access medical care. Video appointments, asynchronous messaging platforms, and app-based consultations now represent a routine first point of contact for everything from antibiotic prescriptions to ongoing chronic disease management.

Convenience, however, is not the same as completeness. When a prescription is written—or adjusted—following a virtual visit, the dosing decision rests on a foundation of information that may be significantly thinner than what a physician would gather during an in-person examination. For patients, understanding where those gaps exist is not a reason to distrust telehealth. It is a reason to approach virtual appointments more actively.

What a Camera Cannot Capture

Dosing is rarely a simple calculation. A physician determining the right starting dose for a new medication, or adjusting an existing one, draws on a range of clinical data points that are not easily transmitted through a screen.

Body weight is one of the most fundamental. Many medications—particularly in oncology, pediatrics, and infectious disease treatment—are dosed on a milligrams-per-kilogram basis. Even for drugs dosed as flat amounts, a patient's weight influences distribution, metabolism, and clearance. During an in-person visit, weight is captured as a matter of routine. During a telehealth appointment, a provider must rely on what the patient self-reports. Research consistently shows that self-reported weight tends to be underestimated, particularly among adults with obesity—a population that already faces unique dosing challenges.

Kidney and liver function are equally critical, and equally invisible through a webcam. Both organs play central roles in how medications are processed and eliminated from the body. A dose that is appropriate for a patient with normal renal function may accumulate to dangerous levels in someone with compromised kidneys. Yet a telehealth provider who does not have access to recent laboratory values—or who does not know to request them—may proceed without that information.

Blood pressure, heart rate, skin condition, visible edema, and the subtle physical findings that physicians are trained to observe during a face-to-face encounter are either absent or imprecisely communicated in a virtual setting. A patient who mentions feeling "a little off" may be describing a side effect that warrants a dose reduction—or something that requires immediate in-person evaluation. The clinical context that helps a physician distinguish between those possibilities is harder to establish remotely.

The Medication History Problem

Accurate prescribing depends on a complete picture of what a patient is already taking. During in-person visits, patients are often prompted to bring their medication bottles, and clinical staff may conduct a formal reconciliation process. Telehealth encounters are rarely structured that way.

A patient joining a video call from their living room may not have their medications nearby. They may not think to mention a supplement they recently started, an over-the-counter pain reliever they take regularly, or a medication prescribed by a specialist that their primary care provider does not have in the chart. These omissions are rarely intentional, but they create real risk. A dose that is appropriate in isolation may be excessive—or insufficient—when combined with other agents the provider does not know about.

The responsibility for closing this gap cannot fall entirely on the physician. In a ten-minute virtual appointment, a provider is managing time constraints that make comprehensive medication review difficult. Patients who prepare before their telehealth appointment—by compiling a current, accurate medication list—meaningfully reduce the chance of a prescribing decision being made without full information.

What Patients Should Bring to Every Virtual Appointment

Approaching a telehealth visit with the same preparation one would bring to an in-person appointment is the single most effective thing a patient can do to support safe dosing. Practically, that means:

A current, complete medication list. This should include every prescription drug, over-the-counter medication, vitamin, and supplement, along with the dose and how often it is taken. If possible, share this list in the patient portal before the appointment begins.

Recent laboratory results. If you have had bloodwork done in the past three to six months—particularly kidney function panels, liver function tests, or complete blood counts—have those values available. If your provider does not reference them and they are relevant to a dosing decision, raise the subject yourself.

An accurate, current body weight. Weigh yourself before the appointment using a home scale, and report that figure to your provider. Do not estimate.

A list of recent symptoms or side effects. If you are being seen for a medication adjustment, document what you have been experiencing, when symptoms occur, and whether they correlate with dosing times. This level of specificity is more useful to a prescriber than a general description.

Questions about monitoring. If a new medication is being started or an existing dose is being changed, ask your provider what follow-up is needed and on what timeline. A telehealth prescription without a defined monitoring plan is an incomplete prescription.

Red Flags That Call for an In-Person Visit

Telehealth is appropriate for a wide range of clinical situations, but there are circumstances in which a virtual appointment is genuinely insufficient for safe dosing decisions. Patients should consider requesting an in-person evaluation when:

• A new medication carries a narrow therapeutic window and requires baseline laboratory assessment before initiation
• A dose adjustment is being considered for a medication that affects cardiac function, kidney filtration, or clotting
• Symptoms being reported could indicate a serious adverse drug reaction that requires physical examination to evaluate
• The patient has not had a comprehensive in-person evaluation in more than a year and has multiple active prescriptions
• The prescribing provider does not have access to the patient's full medical record or specialist notes

None of these circumstances make telehealth an inappropriate tool. They simply identify the boundary between what a virtual visit can safely accomplish and what it cannot.

The Shared Responsibility of Remote Care

The expansion of telehealth has been, on balance, a meaningful improvement in healthcare access for Americans who live in rural areas, face transportation barriers, or manage demanding schedules. The platform itself is not the problem. The problem is the assumption—held by both patients and providers—that a virtual visit is functionally identical to an in-person one.

For dosing decisions specifically, that assumption is worth examining carefully. Safe prescribing is an information-intensive process. The more complete the information available to the provider, the more precisely a dose can be calibrated to the individual patient. In a telehealth setting, patients who take an active role in supplying that information are not being overly cautious. They are participating in their own safety in a way that the format demands.